๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Donepezil for the treatment of psychosis in dementia with Lewy bodies

โœ Scribed by Emma Fergusson; Robert Howard


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
49 KB
Volume
15
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Rivastigmine in the treatment of dementi
โœ Ian G. McKeith; Janet B. Grace; Zuzana Walker; E. Jane Byrne; David Wilkinson; T ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 81 KB ๐Ÿ‘ 1 views

The objective of this study was to assess the tolerability and efficacy of rivastigmine in a group of patients with probable dementia with Lewy bodies (DLB), using an open label study. Open label treatment was with rivastigmine up to maximum tolerated dose (mean 9.6 mg daily, range 3-12 mg). Eleven

Better cognitive and psychopathologic re
โœ William Samuel; Michael Caligiuri; Douglas Galasko; Jonathan Lacro; Merri Marini ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 153 KB

In several retrospective post-mortem studies, patients meeting clinical criteria for Alzheimer's disease (AD) who gained the greatest cognitive beneยฎt from treatment with an acetylcholinesterase (AChE) inhibitor were found to have neocortical Lewy bodies accompanying classical AD neuropathology. Thi

Three years survival in patients with a
โœ Zuzana Walker; Ruth L. Allen; Sukhwinder Shergill; Eleanor Mullan; Cornelius L. ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB ๐Ÿ‘ 1 views

The majority of information available on the prognosis of dementia with Lewy bodies (DLB) is based on retrospective data from autopsy series, which are subject to selection bias due to the speciยฎc reasons patients are referred for postmortem studies. The earlier studies comparing DLB patients with p